BACKGROUND AND PURPOSE

Small fiber neuropathy (SFN), resulting from dysfunction and loss of peripheral unmyelinated and thinly myelinated nerve fibers, is traditionally characterized by distal skin pain and sensory loss. Patients often report additional symptoms, including muscle cramps, myalgias, fatigue, subjective weakness, and neuropathic itch, but the prevalence and intensity of these symptoms remain poorly defined. Current treatments-focused primarily on pain-are often ineffective, possibly due to substantial between-patient heterogeneity. This study aimed to characterize the symptomatic variability of SFN and determine whether patients can be stratified into clinically meaningful subgroups.

METHODS

Demographic, clinical, and laboratory data were analyzed from patients with skin biopsy-confirmed SFN (n = 203) and healthy controls (n = 30). SFN patients were clustered based on clinical features using unsupervised machine learning.

RESULTS

Fatigue-not neuropathic pain-was the most prevalent and intense symptom among patients with SFN. Muscle symptoms were as common and severe as neuropathic pain, while neuropathic itch was rare. Three distinct phenotypic clusters were identified: (1) an "algesic" group (20%) with severe neuropathic pain and co-occurring intense symptoms; (2) a "myalgic" group (60%) with prominent fatigue, myalgias, and subjective weakness but milder neuropathic pain; and (3) a "pauci-symptomatic" group with few, mild to moderate symptoms. Clusters differed by symptom profiles, disease duration, intraepidermal nerve fiber density, sex, and body mass index.

CONCLUSION

Fatigue and muscle symptoms are highly prevalent in SFN and may rival pain in clinical importance. Identifying patient subgroups provides a foundation for stratified treatment approaches and improved disease management.